VFY ASX · Health Care

Vitrafy Life Sciences Ltd

Announcements, last 12 months: 64
Price sensitive, last 12 months: 21

Latest announcements

Released	Headline	Actions
20 Oct 2026, 9:10 AM	Application for quotation of securities - VFY
20 Oct 2026, 8:24 AM	Appointment of Chief Financial Officer
16 Oct 2026, 8:22 AM	2026 Notice of Annual General Meeting
7 Oct 2026, 8:21 AM	Investor Roadshow Presentation
7 Oct 2026, 8:21 AM	Change to CEO Remuneration and Employment Terms
30 Sep 2026, 12:02 PM	Vitrafy enters partnership with Versiti Blood Health Price sensitive	AI summary
4 Sep 2026, 5:10 PM	S&P DJI Announces September 2026 Quarterly Rebalance Price sensitive	AI summary
2 Sep 2026, 9:17 AM	Vitrafy enters U.S. Cell & Gene Therapy Market Price sensitive	AI summary
4 Aug 2026, 8:23 AM	FY26 Corporate Governance Statement
4 Aug 2026, 8:23 AM	FY26 Appendix 4G

Sign in to see all VFY announcements.

Guidance history

2 Sep 2026	No revenue expected in initial 6-month term
4 Aug 2026	Expect U.S. manufacturing capability to be established in the first half of FY2027
19 Jun 2026	Vitrafy aims to raise up to A$2 million through the SPP.

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow VFY to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.